Elevated SET protein levels are observed in various human tumors, including colorectal cancer, gastric cancer, pancreatic cancer, breast cancer, non-small cell lung cancer, and acute myeloid leukemia, and SET levels are correlated with poor prognosis and drug-resistance [11–16]. This evidence concerns the gene SET and acute myeloid leukemia.